Mirae Asset Global Investments Co., Ltd. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$814,618
-44.1%
39,583
+27.6%
0.00%
-33.3%
Q2 2023$1,458,418
+6.4%
31,022
-5.1%
0.00%0.0%
Q1 2023$1,371,295
+36.0%
32,681
+23.6%
0.00%0.0%
Q4 2022$1,008,193
-2.5%
26,434
+0.1%
0.00%0.0%
Q3 2022$1,034,000
+95.1%
26,411
+61.0%
0.00%
+200.0%
Q2 2022$530,000
+76.7%
16,408
+310.4%
0.00%0.0%
Q1 2021$300,000
-28.1%
3,998
-17.0%
0.00%
-50.0%
Q4 2020$417,000
+53.9%
4,814
+8.6%
0.00%
+100.0%
Q3 2020$271,000
-6.9%
4,434
-56.2%
0.00%
-50.0%
Q1 2020$291,000
-69.2%
10,126
-22.6%
0.00%
-66.7%
Q4 2019$945,000
-36.5%
13,079
+23.3%
0.01%
-40.0%
Q3 2019$1,488,000
-19.6%
10,604
+4.9%
0.01%
-23.1%
Q2 2019$1,851,000
+21.4%
10,111
+5.5%
0.01%
+18.2%
Q1 2019$1,525,000
+83.5%
9,584
+10.5%
0.01%
+37.5%
Q4 2018$831,000
-30.3%
8,676
+2.8%
0.01%
-11.1%
Q3 2018$1,192,000
+8.1%
8,437
+19.7%
0.01%
-40.0%
Q2 2018$1,103,000
-3.1%
7,046
-0.3%
0.02%0.0%
Q1 2018$1,138,000
+16.1%
7,068
+18.8%
0.02%
+15.4%
Q4 2017$980,000
+264.3%
5,950
+38.0%
0.01%
+160.0%
Q3 2017$269,000
-84.9%
4,312
-80.7%
0.01%
-83.9%
Q2 2017$1,777,000
+12.0%
22,3120.0%0.03%
+3.3%
Q1 2017$1,586,000
+66.4%
22,312
+19.6%
0.03%
+42.9%
Q4 2016$953,000
-0.6%
18,658
-10.3%
0.02%
+5.0%
Q3 2016$959,00020,8110.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders